PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Works matching IS 11727047 AND DT 2014 AND VI 28 AND IP 6
Results: 9
1
2
Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-β: evaluation as biomarkers for clinical response.
- Published in:
- 2014
- By:
- Publication type:
- journal article
3
Killer-Cell Immunoglobulin-Like Receptor Expression on Lymphocyte Subsets in Multiple Sclerosis Patients Treated with Interferon-β: Evaluation as Biomarkers for Clinical Response.
- Published in:
- CNS Drugs, 2014, v. 28, n. 6, p. 559, doi. 10.1007/s40263-014-0153-7
- By:
- Publication type:
- Article
4
Role of Atypical Antipsychotics in the Treatment of Generalized Anxiety Disorder.
- Published in:
- CNS Drugs, 2014, v. 28, n. 6, p. 519, doi. 10.1007/s40263-014-0162-6
- By:
- Publication type:
- Article
5
Changes in Gait Variability with Anti-dementia Drugs: A Systematic Review and Meta-analysis.
- Published in:
- CNS Drugs, 2014, v. 28, n. 6, p. 513, doi. 10.1007/s40263-014-0170-6
- By:
- Publication type:
- Article
6
A Systematic Review of the Safety of Lisdexamfetamine Dimesylate.
- Published in:
- CNS Drugs, 2014, v. 28, n. 6, p. 497, doi. 10.1007/s40263-014-0166-2
- By:
- Publication type:
- Article
7
PPAR-γ Agonism as a Modulator of Mood: Proof-of-Concept for Pioglitazone in Bipolar Depression.
- Published in:
- CNS Drugs, 2014, v. 28, n. 6, p. 571, doi. 10.1007/s40263-014-0158-2
- By:
- Publication type:
- Article
8
Immunological Mechanism of Action and Clinical Profile of Disease-Modifying Treatments in Multiple Sclerosis.
- Published in:
- CNS Drugs, 2014, v. 28, n. 6, p. 535, doi. 10.1007/s40263-014-0160-8
- By:
- Publication type:
- Article
9
Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?
- Published in:
- CNS Drugs, 2014, v. 28, n. 6, p. 491, doi. 10.1007/s40263-014-0164-4
- By:
- Publication type:
- Article